580P AT1412, a patient-derived CD9 antibody promotes tumour immune infiltration and induces tumour rejection.
Saved in:
| Title: | 580P AT1412, a patient-derived CD9 antibody promotes tumour immune infiltration and induces tumour rejection. |
|---|---|
| Authors: | Schotte, R.1 (AUTHOR), Villaudy, J.1 (AUTHOR), Kedde, M.1 (AUTHOR), Pos, W.1 (AUTHOR), Wagner, K.1 (AUTHOR), Go, D.1 (AUTHOR), Fatmawati, C.1 (AUTHOR), Moiset, G.1 (AUTHOR), Yasuda, E.1 (AUTHOR), Cercel, M.1 (AUTHOR), Frankin, E.1 (AUTHOR), van Hal-van Veen, S.1 (AUTHOR), van Helden, P.1 (AUTHOR), Verdegaal, E.M.E.2 (AUTHOR), van Eenennaam, H.1 (AUTHOR), van der Burg, S.H.2 (AUTHOR), Spits, H.1 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS492-S492. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2020.08.694 |
